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Background
Mammalian cell cultures, especially Chinese Hamster
Ovary (CHO), are the predominant host for the produc-
tion of biologics. Despite considerable progress in indus-
try and academia alike (also enforced e.g. by the Process
Analytical Technology Initiative of the FDA), particu-
larly in the field of process monitoring there is still a
need for innovative methods enabling improvement of
process monitoring. For optimized process control it
would be imperative to know as early as possible “when
a cell needs what”, when it is stressed, running into sub-
strate limitations etc., at best in an online or robust at
line format.
Intact cell MALDI mass spectrometry (ICM-MS) bio-
typing, a method used successfully in the field of clinical
and environmental microbiology, is getting more atten-
tion in the context of mammalian cell cultivation. Here
we report preliminary results of an assessment of a fast
and high throughput at line capable ICM MS method
for cell culture monitoring. As a first example, we
choose apoptosis monitoring.
The identification of specific mass spectrometric sig-
natures related to early stages of apoptosis using ICM-
MS biotyping as reported here could be a promising
tool for CHO culture.
Material and methods
An exponentially growing CHO suspension cell line was
inoculated at a seeding density of 2 × 105 cells/ml and an
initial volume of 30 ml in 125 ml Erlenmeyer flasks.
Samples for assessing viability- and apoptosis-progression
and for ICM MS biotyping were taken at 48, 72, 96, 120,
144, 192 and 240 h. Experiments were carried out as bio-
logical triplicates.
Viability was determined by trypan blue dye exclusion
using a ViCell (Beckman Coulter, Krefeld, Germany) for
automated processing. Apoptosis was measured in tripli-
cate for each biological sample by means of caspase-9
activity (Caspase-Glo®9 assay kit; Promega, Mannheim,
Germany) using a microplate format (plate reader
POLARstar Omega, BMG Labtech, Ortenberg, Germany).
ICM MS biotyping (using a Bruker Autoflex III
MALDI-TOF/TOF MS) analysis samples were prepared
from as little as 2500 cells. The method is described in
detail by Munteanu et al. (2012) [1].
Results
To evaluate the power of ICM MS as an at-line analyti-
cal method for apoptosis monitoring, batch cultivations
of CHO suspension cells were analyzed by standard ana-
lytical methods and ICM MS in comparison.
Cell viabilities as assessed by trypan blue remained con-
stant over 120 h of batch cultures. A first drop in cell
viability was noticed between 120 and 144 h (Figure 1 a).
In ICM MS analysis, a total of approx. 160 m/z values
was monitored in a mass to charge (m/z) range of 4,000
to 30,000. Principle component analysis (PCA; Figure 1
c) of ICM MS results showed no clear group discrimina-
tion during the first 96 h of cultivation. Interestingly,
cell samples obtained from 120 h of cultivation onwards
appear as distinct groups in PCA analysis.
The concentration of the monitored apoptosis mar-
ker (caspase-9 activity; Figure 1 b) began to increase
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between 96 and 120 h, i.e. concomitantly with PCA
analysis (Figure 1).
As a result, ICM MS as reported here allowed for
rapid detection of cell viability changes approx. 24 h
earlier than standard culture monitoring and concomi-
tant with the detection of an early, not “at-line” applic-
able apoptosis marker.
Closer data analysis allowed the identification of an
apoptosis related subset of m/z values. Using the soft-
ware ClinProTools (CPT; Bruker Daltonik) it was possi-
ble to develop a classification model which points
toward classification of unknown samples regarding
their viability/apoptosis state (Table 1). The classifica-
tion power was illustrated as positive predictive value
(PPV) which is the number of correctly classified
samples over the total number of classified samples. All
biological samples were analyzed as 6-8 technical repli-
cates, meaning in theory a PPV > 50% is sufficient for
classification.
Conclusion
We introduced a fast and robust ICM MS method for
predictive cell culture monitoring. Viability changes can
be detected up to 24 h earlier compared to standard
methods (e.g. trypan blue).
We identified a specific MS signature (condensed sub-
set of original spectra) of m/z values related to cell
stress and apoptosis.
Figure 1 Viability (a), caspase-9 activity (b) and ICM MS biotyping (c) during batch cultivation. FC RLU: Fold change of relative
luminescence units; PC: Principal component of the respective analysis. (a) and (b): given are means of measurements of three experiments (i.e.
n = 3) ± SD; (3): each dot represents one ICM MS measurement. Dashed lines illustrate at which point culture alteration is detectable with the
respective method.
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A model built on the basis of this signature allows
classification of unknown samples regarding their viabi-
lity/apoptosis level.
These results will be substantiated by assessment of
further cell lines as well as monitoring attributes other
than cell stress/apoptosis (e.g. product titer or metabo-
lite progression).
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Table 1 Details of classifying “unknown” samples using the CPT model
“unknown” sample [h] Drop of viability [Y/N] Apoptosis detection [Y/N] Class PPV [%]





120 N Y Early apoptotic 83
144 Y Y Late apoptotic 100
192 Y Y
240 Y Y
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